| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.077 | 0.1 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.25 | 0.2 |